Best Cancer Screening Tests in 2026
Multi-cancer early detection (MCED) tests represent a paradigm shift in cancer screening. Instead of testing for one cancer at a time, these blood tests scan for signals from dozens of cancer types simultaneously. We compared ten cancer screening services, from established tests like Cologuard for colon cancer to new liquid biopsies like Galleri that screen for 50+ cancers. Prices range from $79 for single-cancer tests to $949 for comprehensive MCED panels. The technology is advancing rapidly, but not all tests have equal clinical validation. Some have FDA approval while others operate as laboratory-developed tests. This guide explains what current tests can and cannot detect, and who should consider screening beyond standard guidelines.
Quick Comparison
At-a-glance comparison of our top picks. Updated Jan 2026
| Rank | Provider | Price | Best For |
|---|---|---|---|
| 1 | Galleri by GRAIL | $949 | High-risk individuals wanting comprehensive screening |
| 2 | Shield by Guardant | $895 | Adults 45+ wanting non-invasive CRC screening |
| 3 | Cologuard by Exact Sciences | $649 | Adults 45+ preferring home collection for CRC screening |
| 4 | Signatera by Natera | $Variable | Cancer patients monitoring for recurrence |
| 5 | Prenetics CIRCLE | $399 | Those wanting affordable multi-cancer screening |
| 6 | Freenome | $Variable | Those interested in emerging MCED technology |
Top Picks
Detailed breakdown of each recommended option with pros, cons, and who it's best for.
Galleri by GRAIL
Shield by Guardant
Cologuard by Exact Sciences
Signatera by Natera
Prenetics CIRCLE
Freenome
How We Chose These Picks
Frequently Asked Questions
What's the difference between Galleri and traditional cancer screening?
Traditional screening tests (mammograms, colonoscopies, PSA tests) look for one specific cancer each. Galleri analyzes cell-free DNA in blood to detect signals from 50+ cancer types, including many without standard screening tests. Galleri supplements rather than replaces traditional screening. Its strength is finding cancers that would otherwise be detected only after symptoms appear, often at later stages.
How accurate are multi-cancer early detection tests?
Galleri detects approximately 50% of stage 1-3 cancers across all types, with higher sensitivity for later-stage and certain aggressive cancers. Specificity is about 99.5%, meaning 0.5% false positive rate. For specific cancers, traditional screening may be more sensitive, but MCED catches cancers that lack any screening option. No test catches everything, and negative results don't guarantee you're cancer-free.
Who should consider multi-cancer screening tests?
People at elevated cancer risk due to age (50+), family history, or genetic predisposition may benefit most. Those with access to timely follow-up care get more value since positive results require additional testing. MCED tests are not recommended as the only screening approach since they complement but don't replace colonoscopy, mammography, and other proven screens. Cost and insurance coverage also factor into the decision.
What happens if a multi-cancer test is positive?
A positive result triggers additional diagnostic testing to locate and confirm the cancer. MCED tests predict the likely cancer origin, but imaging and potentially biopsy confirm the finding. This process may involve weeks of uncertainty and multiple appointments. Approximately 1-2% of positive results are false positives that don't find cancer after workup. Discuss the implications with your doctor before testing.
Are these tests covered by insurance?
Coverage varies significantly. Cologuard for colorectal screening is widely covered. Newer MCED tests like Galleri typically aren't covered by insurance or Medicare. Some employers and concierge medicine practices include them in health benefits. Prices range from $600-950 out of pocket. As clinical evidence accumulates, coverage is expected to expand over the next several years.
Ready to Get Started?
Compare all options and find the best fit for your health goals.
View All Cancer Screening OptionsImportant Disclaimer
This comparison is for informational purposes only and is not medical advice. Prices are based on January 2026 data and may vary. Consult with a healthcare provider before making health-related decisions.